In vitro activity of eravacycline against common ribotypes of Clostridioides difficile

BACKGROUND: Eravacycline is a novel synthetic fluorocycline antibacterial approved for complicated intra-abdominal infections. OBJECTIVES: The purpose of this study was to assess the in vitro activities of eravacycline and comparator antibiotics against contemporary clinical isolates of Clostridioid...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Antimicrob Chemother
Egile Nagusiak: Bassères, Eugénie, Begum, Khurshida, Lancaster, Chris, Gonzales-Luna, Anne J, Carlson, Travis J, Miranda, Julie, Rashid, Tasnuva, Alam, M Jahangir, Eyre, David W, Wilcox, Mark H, Garey, Kevin W
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2020
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7678891/
https://ncbi.nlm.nih.gov/pubmed/32719870
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkaa289
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak